BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24852370)

  • 1. Genome-wide association study identifies a novel susceptibility gene for serum TSH levels in Chinese populations.
    Zhan M; Chen G; Pan CM; Gu ZH; Zhao SX; Liu W; Wang HN; Ye XP; Xie HJ; Yu SS; Liang J; Gao GQ; Yuan GY; Zhang XM; Zuo CL; Su B; Huang W; Ning G; Chen SJ; Chen JL; Song HD;
    Hum Mol Genet; 2014 Oct; 23(20):5505-17. PubMed ID: 24852370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication confirms the association of loci in FOXE1, PDE8B, CAPZB and PDE10A with thyroid traits: a Genetics of Diabetes Audit and Research Tayside study (GoDARTS).
    Soto-Pedre E; Siddiqui MK; Doney AS; Palmer CNA; Pearson ER; Leese GP
    Pharmacogenet Genomics; 2017 Oct; 27(10):356-362. PubMed ID: 28727628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.
    Wang YL; Feng SH; Guo SC; Wei WJ; Li DS; Wang Y; Wang X; Wang ZY; Ma YY; Jin L; Ji QH; Wang JC
    J Med Genet; 2013 Oct; 50(10):689-95. PubMed ID: 23847140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2.
    He H; Li W; Liyanarachchi S; Jendrzejewski J; Srinivas M; Davuluri RV; Nagy R; de la Chapelle A
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E164-72. PubMed ID: 25303483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
    Sigurdson AJ; Brenner AV; Roach JA; Goudeva L; Müller JA; Nerlich K; Reiners C; Schwab R; Pfeiffer L; Waldenberger M; Braganza M; Xu L; Sturgis EM; Yeager M; Chanock SJ; Pfeiffer RM; Abend M; Port M
    Carcinogenesis; 2016 Jul; 37(7):677-684. PubMed ID: 27207655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. rs965513 polymorphism as a common risk marker is associated with papillary thyroid cancer.
    Wang F; Yan D; Ji X; Han J; Chen M; Qiao H; Zhang S
    Oncotarget; 2016 Jul; 7(27):41336-41345. PubMed ID: 27191655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype Analyses in the Japanese and Belarusian Populations Reveal Independent Effects of rs965513 and rs1867277 but Do Not Support the Role of FOXE1 Polyalanine Tract Length in Conferring Risk for Papillary Thyroid Carcinoma.
    Nikitski AV; Rogounovitch TI; Bychkov A; Takahashi M; Yoshiura KI; Mitsutake N; Kawaguchi T; Matsuse M; Drozd VM; Demidchik Y; Nishihara E; Hirokawa M; Miyauchi A; Rubanovich AV; Matsuda F; Yamashita S; Saenko VA
    Thyroid; 2017 Feb; 27(2):224-235. PubMed ID: 27824288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
    He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
    Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.
    Kula D; Kalemba M; Puch Z; Polańska J; Świerniak M; Rusinek D; Żebracka-Gala J; Kowalska M; Handkiewicz-Junak D; Kowal M; Tyszkiewicz T; Piasna E; Czarniecka A; Pawlaczek A; Krajewska J; Szpak-Ulczok S; Jarząb B
    Endokrynol Pol; 2017; 68(3):283-289. PubMed ID: 28660995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations.
    Gudmundsson J; Sulem P; Gudbjartsson DF; Jonasson JG; Sigurdsson A; Bergthorsson JT; He H; Blondal T; Geller F; Jakobsdottir M; Magnusdottir DN; Matthiasdottir S; Stacey SN; Skarphedinsson OB; Helgadottir H; Li W; Nagy R; Aguillo E; Faure E; Prats E; Saez B; Martinez M; Eyjolfsson GI; Bjornsdottir US; Holm H; Kristjansson K; Frigge ML; Kristvinsson H; Gulcher JR; Jonsson T; Rafnar T; Hjartarsson H; Mayordomo JI; de la Chapelle A; Hrafnkelsson J; Thorsteinsdottir U; Kong A; Stefansson K
    Nat Genet; 2009 Apr; 41(4):460-4. PubMed ID: 19198613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel associations for hypothyroidism include known autoimmune risk loci.
    Eriksson N; Tung JY; Kiefer AK; Hinds DA; Francke U; Mountain JL; Do CB
    PLoS One; 2012; 7(4):e34442. PubMed ID: 22493691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?
    Ai L; Yu Y; Liu X; Wang C; Shi J; Sun H; Yu Q
    Front Med; 2014 Mar; 8(1):113-7. PubMed ID: 24452548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
    Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
    Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus.
    Wang Y; He H; Li W; Phay J; Shen R; Yu L; Hancioglu B; de la Chapelle A
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):474-479. PubMed ID: 28049826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.
    Wei WJ; Lu ZW; Wang Y; Zhu YX; Wang YL; Ji QH
    Cancer Genet; 2015 Mar; 208(3):68-75. PubMed ID: 25746573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function.
    Porcu E; Medici M; Pistis G; Volpato CB; Wilson SG; Cappola AR; Bos SD; Deelen J; den Heijer M; Freathy RM; Lahti J; Liu C; Lopez LM; Nolte IM; O'Connell JR; Tanaka T; Trompet S; Arnold A; Bandinelli S; Beekman M; Böhringer S; Brown SJ; Buckley BM; Camaschella C; de Craen AJ; Davies G; de Visser MC; Ford I; Forsen T; Frayling TM; Fugazzola L; Gögele M; Hattersley AT; Hermus AR; Hofman A; Houwing-Duistermaat JJ; Jensen RA; Kajantie E; Kloppenburg M; Lim EM; Masciullo C; Mariotti S; Minelli C; Mitchell BD; Nagaraja R; Netea-Maier RT; Palotie A; Persani L; Piras MG; Psaty BM; Räikkönen K; Richards JB; Rivadeneira F; Sala C; Sabra MM; Sattar N; Shields BM; Soranzo N; Starr JM; Stott DJ; Sweep FC; Usala G; van der Klauw MM; van Heemst D; van Mullem A; Vermeulen SH; Visser WE; Walsh JP; Westendorp RG; Widen E; Zhai G; Cucca F; Deary IJ; Eriksson JG; Ferrucci L; Fox CS; Jukema JW; Kiemeney LA; Pramstaller PP; Schlessinger D; Shuldiner AR; Slagboom EP; Uitterlinden AG; Vaidya B; Visser TJ; Wolffenbuttel BH; Meulenbelt I; Rotter JI; Spector TD; Hicks AA; Toniolo D; Sanna S; Peeters RP; Naitza S
    PLoS Genet; 2013; 9(2):e1003266. PubMed ID: 23408906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population.
    Maillard S; Damiola F; Clero E; Pertesi M; Robinot N; Rachédi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Doyon F; Xhaard C; Rubino C; Blanché H; Drozdovitch V; Lesueur F; de Vathaire F
    PLoS One; 2015; 10(4):e0123700. PubMed ID: 25849217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A locus on chromosome 1p36 is associated with thyrotropin and thyroid function as identified by genome-wide association study.
    Panicker V; Wilson SG; Walsh JP; Richards JB; Brown SJ; Beilby JP; Bremner AP; Surdulescu GL; Qweitin E; Gillham-Nasenya I; Soranzo N; Lim EM; Fletcher SJ; Spector TD
    Am J Hum Genet; 2010 Sep; 87(3):430-5. PubMed ID: 20826269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis.
    Kang J; Deng XZ; Fan YB; Wu B
    Tumour Biol; 2014 Jul; 35(7):7085-96. PubMed ID: 24756757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatic Mutations of FOXE1 in Papillary Thyroid Cancer.
    Mond M; Bullock M; Yao Y; Clifton-Bligh RJ; Gilfillan C; Fuller PJ
    Thyroid; 2015 Aug; 25(8):904-10. PubMed ID: 25950909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.